valproic acid has been researched along with neuropeptide y in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydin, K; Bideci, A; Gucuyener, K; Okuyaz, C; Serdaroglu, A | 1 |
| Brill, J; Fernald, RD; Huguenard, JR; Lee, M; Zhao, S | 1 |
| Foti, S; Gallagher, M; Haberman, RP; Koh, MT; McCown, TJ | 1 |
| Camurdan, O; Cansu, A; Cinaz, P; Hırfanoğlu, T; Serdaroglu, A | 1 |
| Aydin, K; Kiyici, A; Oran, B; Tokgoz, H | 1 |
| Demir, CF; Inci, MF; Ozkan, F | 1 |
| Aydin, K; Oran, B; Tokgoz, H | 1 |
| Aksoy, A; Aliyazicioglu, R; Deger, O; Fazlioglu, K; Karaguzel, G; Sonmez, FM; Zaman, D | 1 |
| Farrelly, LA; O'Callaghan, C; Savage, NT; Toulouse, A; Yilmazer-Hanke, DM | 1 |
| Dedeurwaerdere, S; Elms, J; Morris, MJ; O'Brien, TJ; Powell, KL; van Raay, L | 1 |
| Blanco, MM; Cinini, SM; Lima, TZ; Mello, LE; Pontes, JC; Queiroz, CM | 1 |
| Alver, A; Cansu, A; Çiçek, NP; Kamaşak, T; Okten, A; Serin, M | 1 |
1 trial(s) available for valproic acid and neuropeptide y
| Article | Year |
|---|---|
Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate.
Topics: Anticonvulsants; Blood Glucose; Body Mass Index; Child; Child, Preschool; Epilepsy; Female; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Leptin; Male; Neuropeptide Y; Valproic Acid; Weight Gain | 2005 |
11 other study(ies) available for valproic acid and neuropeptide y
| Article | Year |
|---|---|
Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami.
Topics: Action Potentials; Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Arginine; Drug Administration Schedule; Gene Expression Regulation; Immunohistochemistry; In Vitro Techniques; Midline Thalamic Nuclei; Neuropeptide Y; Phosphopyruvate Hydratase; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Valproic Acid | 2006 |
Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment.
Topics: Age Factors; Aging; Animals; Anticonvulsants; CA3 Region, Hippocampal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Levetiracetam; Male; Maze Learning; Neuropeptide Y; Peptide Fragments; Piracetam; Rats; Rats, Long-Evans; Space Perception; Transduction, Genetic; Valproic Acid | 2010 |
Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate.
Topics: Adolescent; Child; Child, Preschool; Epilepsy; Galanin; Ghrelin; Humans; Hydrocortisone; Insulin; Leptin; Neuropeptide Y; Valproic Acid; Weight Gain | 2011 |
Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate.
Topics: Adiponectin; Age Factors; Anticonvulsants; Blood Glucose; Body Mass Index; Carotid Intima-Media Thickness; Child; Epilepsy; Female; Follow-Up Studies; Ghrelin; Humans; Insulin; Leptin; Male; Neuropeptide Y; Valproic Acid | 2012 |
Importance of accurate measurement of carotid intima-media thickness for evaluating epileptic children treated with valproate.
Topics: Adiponectin; Anticonvulsants; Carotid Intima-Media Thickness; Epilepsy; Female; Ghrelin; Humans; Leptin; Male; Neuropeptide Y; Valproic Acid | 2013 |
Reply from the authors of the article entitled "Importance of accurate measurement of carotid intima media thickness for evaluating epileptic children treated with valproate".
Topics: Adiponectin; Anticonvulsants; Carotid Intima-Media Thickness; Epilepsy; Female; Ghrelin; Humans; Leptin; Male; Neuropeptide Y; Valproic Acid | 2013 |
The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy.
Topics: Adiponectin; Anticonvulsants; Body Mass Index; Body Weight; C-Peptide; Child; Epilepsy; Female; Fructose; Humans; Insulin; Leptin; Male; Neuropeptide Y; Nicotinamide Phosphoribosyltransferase; Resistin; Topiramate; Valproic Acid | 2013 |
Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
Topics: Amitriptyline; Anticonvulsants; Cell Line, Tumor; Cell Survival; Gene Expression; Humans; Neuroblastoma; Neuropeptide Y; Tetradecanoylphorbol Acetate; Valproic Acid | 2013 |
Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsy.
Topics: Animals; Anticonvulsants; Brain; Epilepsy, Absence; Male; Neuropeptide Y; Rats; Rats, Wistar; Seizures; Up-Regulation; Valproic Acid | 2013 |
Seizures triggered by pentylenetetrazol in marmosets made chronically epileptic with pilocarpine show greater refractoriness to treatment.
Topics: Animals; Anticonvulsants; Brain; Callithrix; Carbamazepine; Chronic Disease; Disease Models, Animal; Electrocorticography; Epilepsy; Female; Immunohistochemistry; Male; Neuropeptide Y; Pentylenetetrazole; Phenobarbital; Pilocarpine; Proto-Oncogene Proteins c-fos; Seizures; Valproic Acid | 2016 |
The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
Topics: Adolescent; Anticonvulsants; Biomarkers; Blood Glucose; Body Mass Index; Child; Epilepsy; Fructose; Ghrelin; Humans; Insulin; Leptin; Neuropeptide Y; Topiramate; Treatment Outcome; Valproic Acid; Weight Gain | 2018 |